Methylcobalamin as a candidate for chronic peripheral neuropathic pain therapy: review of molecular pharmacology action
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Chronic peripheral neuropathic pain therapy currently focuses on modulating neuroinflammatory conditions. Methylcobalamin (MeCbl), a neuroregenerative agent, modulates neuroinflammation. This review aimed to explore the molecular pharmacology action of MeCbl as a chronic peripheral neuropathic pain therapeutic agent. MeCbl plays a role in various cellular processes and may have therapeutic potential in neurodegenerative diseases. Intracellular MeCbl modulates inflammation by regulating the activity of T lymphocytes and natural killer cells as well as secretion of inflammatory cytokines, namely, tumor necrosis factor-α, interleukin-6, interleukin-1β, epidermal growth factor, and neuronal growth factor. MeCbl can reduce pain symptoms in chronic neuropathic pain conditions by decreasing excitation and hyperpolarization-induced ion channel activity in medium-sized dorsal root ganglion (DRG) neurons and the expression of transient receptor potential ankyrin 1, transient receptor potential cation channel subfamily M member 8, phosphorylated p38MAPK, transient receptor potential cation channel subfamily V members 1 and 4 in the DRG, and the voltage-gated sodium channel in axons.
Abstract
Chronic peripheral neuropathic pain therapy currently focuses on modulating neuroinflammatory conditions. Methylcobalamin (MeCbl), a neuroregenerative agent, modulates neuroinflammation. This review aimed to explore the molecular pharmacology action of MeCbl as a chronic peripheral neuropathic pain therapeutic agent. MeCbl plays a role in various cellular processes and may have therapeutic potential in neurodegenerative diseases. Intracellular MeCbl modulates inflammation by regulating the activity of T lymphocytes and natural killer cells as well as secretion of inflammatory cytokines, namely, tumor necrosis factor-α, interleukin-6, interleukin-1β, epidermal growth factor, and neuronal growth factor. MeCbl can reduce pain symptoms in chronic neuropathic pain conditions by decreasing excitation and hyperpolarization-induced ion channel activity in medium-sized dorsal root ganglion (DRG) neurons and the expression of transient receptor potential ankyrin 1, transient receptor potential cation channel subfamily M member 8, phosphorylated p38MAPK, transient receptor potential cation channel subfamily V members 1 and 4 in the DRG, and the voltage-gated sodium channel in axons.
참고문헌 (55)
- Baskozos G, "Epidemiology of neuropathic pain : an analysis of prevalence and associated factors in UK Biobank", Pain Rep, 8, pp.e1066~ (2023)
- VanDenKerkhof EG, "An epidemiological study of neuropathic pain symptoms in Canadian adults", Pain Res Manag, 2016, pp.9815750~ (2016)
- DiBonaventura MD, "The prevalence of probable neuropathic pain in the US : results from a multimodal general-population health survey", J Pain Res, 10, pp.2525~2538 (2017)
- Sommer C, "Inflammation in the pathophysiology of neuropathic pain", Pain, 159, pp.595~602 (2018)
- Ellis A, "Neuroinflammation and the generation of neuropathic pain", Br J Anaesth, 111, pp.26~37 (2013)
- Finnerup NB, "Pharmacotherapy for neuropathic pain in adults : a systematic review and meta-analysis", Lancet Neurol, 14, pp.162~173 (2015)
- Chung MK, "Acute and chronic pain from facial skin and oral mucosa : unique neurobiology and challenging treatment", Int J Mol Sci, 22, pp.5810~ (2021)
- Cartwright C, "Long-term antidepressant use : patient perspectives of benefits and adverse effects", Patient Prefer Adherence, 10, pp.1401~1407 (2016)
- Buesing S, "Vitamin B12 as a treatment for pain", Pain Physician, 22, pp.E45~E52 (2019)
- "Methylcobalamin: summary report" (2020)[URL]
- Jaya MKA, "Effectivity analysis of neuroprotector(Vitamin B complex and mecobalamin)as neuropathic pain supportive therapy in elderly with type 2 diabetes mellitus", Asian J Pharm Clin Res, 10, pp.320~323 (2017)
- : results of a pilot study, "Ann Indian Acad Neurol", 2014, 19~24
- Li S, "Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy : a multicenter, randomized, double-blind, controlled trial", J Diabetes Investig, 7, pp.777~785 (2016)
- Xǔ G, "Local injection of methylcobalamin combined with lidocaine for acute herpetic neuralgia", Pain Med, 17, pp.572~581 (2016)
- Xu G, "A singlecenter randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia", Pain Med, 14, pp.884~894 (2013)
- Xu G, "Local administration of methylcobalamin for subacute ophthalmic herpetic neuralgia : a randomized, phase III clinical trial", Pain Pract, 20, pp.838~849 (2020)
- Xǔ G, "Local administration of methylcobalamin and lidocaine for acute ophthalmic herpetic neuralgia : a single-center randomized controlled trial", Pain Pract, 16, pp.869~881 (2016)
- Han X, "Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma", BMC Cancer, 17, pp.40~ (2017)
- Metin SK, "The effect of pregabalin and methylcobalamin combination on the chronic postthoracotomy pain syndrome", Ann Thorac Surg, 103, pp.1109~1113 (2017)
- Singh PM, "Analgesic efficacy and safety of medical therapy alone vs combined medical therapy and extraoral glossopharyngeal nerve block in glossopharyngeal neuralgia", Pain Med, 14, pp.93~102 (2013)
- Takeda M, "Peripheral and central mechanisms of trigeminal neuropathic and inflammatory pain", J Oral Biosci, 53, pp.318~329 (2011)
- Costa GMF, "Demyelination", remyelination and expression of interleukin-1β, substance P, nerve growth factor, and glial-derived neurotrophic factor during trigeminal neuropathic pain in rats, 2016, pp.612, 210~218
- Shinoda M, "Orofacial neuropathic pain-basic research and their clinical relevancies", Front Mol Neurosci, 14, pp.691396~ (2021)
- Fex Svennigsen A, "Repair of the peripheral nerve—Remyelination that works", Brain Sci, 3, pp.1182~1197 (2013)
- "PubChem Compound Summary for CID 123134034, Methylcobalamin" (2004)[URL]
- Arslan ŞA, "Cobalamins and methylcobalamin : coenzyme of vitamin B12", FABAD J Pharm Sci, 38, pp.151~157 (2013)
- Smith AD, "Vitamin B12", Adv Food Nutr Res, 83, pp.215~279 (2018)
- Fidaleo M, "Current nanocarrier strategies improve vitamin B12 pharmacokinetics, ameliorate patients'lives, and reduce costs", Nanomaterials (Basel), 11, pp.743~ (2021)
- Netsomboon K, "Vitamin B12 and derivatives-In vitro permeation studies across Caco-2 cell monolayers and freshly excised rat intestinal mucosa", Int J Pharm, 497, pp.129~135 (2016)
- Hanawa A, "In vivo real-time simultaneous examination of drug kinetics at two separate locations using boron-doped diamond microelectrodes", Anal Chem, 92, pp.13742~13749 (2020)
- Wheatley C, "The return of the Scarlet Pimpernel : cobalamin in inflammation II-cobalamins can both selectively promote all three nitric oxide synthases(NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS", J Nutr Environ Med, 16, pp.181~211 (2007)
- Chu RC, "The methylcobalamin metabolism of cultured human fibroblasts", Metabolism, 42, pp.315~319 (1993)
- Zhang Y, "Neuregulin 1 promotes glutathione-dependent neuronal cobalamin metabolism by stimulating cysteine uptake", Oxid Med Cell Longev, 2016, pp.3849087~ (2016)
- Temova Rakuša Ž, "Vitamin B12 in foods, food supplements, and medicines—A review of its role and properties with a focus on its stability", Molecules, 28, pp.240~ (2022)
- Paul C, "Comparative bioavailability and utilization of particular forms of B12 supplements with potential to mitigate B12-related genetic polymorphisms", Integr Med (Encinitas), 16, pp.42~49 (2017)
- Jarrett JT, "Mutations in the B12-binding region of methionine synthase : how the protein controls methylcobalamin reactivity", Biochemistry, 35, pp.2464~2475 (1996)
- Kramer PR, "Role for the ventral posterior medial", posterior lateral thalamus and anterior cingulate cortex in affective, Front Integr Neurosci, pp.2017, 11[DOI]
- Obeid R, "Cobalamin coenzyme forms are not likely to be superior to cyano-and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency", Mol Nutr Food Res, 59, pp.1364~1372 (2015)
- Scalabrino G, "New insights into the pathophysiology of cobalamin deficiency", Trends Mol Med, 12, pp.247~254 (2006)
- Scalabrino G, "Cobalamin(vitamin B(12))positively regulates interleukin-6 levels in rat cerebrospinal fluid", J Neuroimmunol, 127, pp.37~43 (2002)
- Chemaly SM, "Naturally occurring cobalamins have antimalarial activity", J Inorg Biochem, 101, pp.764~773 (2007)
- Weinberg JB, "Inhibition of nitric oxide synthase by cobalamins and cobinamides", Free Radic Biol Med, 46, pp.1626~1632 (2009)
- Rafiee S, "Vitamin B12 inhibits tau fibrillization via binding to cysteine residues of tau", ACS Chem Neurosci, 8, pp.2676~2682 (2017)
- Shah T, "Molecular and cellular effects of vitamin B12 forms on human trophoblast cells in presence of excessive folate", Biomed Pharmacother, 84, pp.526~534 (2016)
- Narayanan N, "Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12from the SARS-CoV-2 virus", IUBMB Life, 72, pp.2112~2120 (2020)
- Xu J, "Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats : effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn", Mol Pain, 12, pp.1744806916657089~ (2016)
- Zhang M, "Inhibition of hyperpolarization-activated cation current in medium-sized DRG neurons contributed to the antiallodynic effect of methylcobalamin in the rat of a chronic compression of the DRG", Neural Plast, 2015, pp.197392~ (2015)
- Mutiawati E, "A preliminary study on the effect of methylcobalamin application on reducing neuropathic pain", Hum Vet Med, 7, pp.101~103 (2015)
- Mutiawati E, "Effect of methylcobalamin on voltagegated sodium channels(VGSCS)expression in neuropathic painanimal model", Biomed Pharmacol J, 14, pp.1033~1038 (2021)
- Zhang D, "Therapeutic effect of Tetrapanax papyriferus and hederagenin on chronic neuropathic pain of chronic constriction injury of sciatic nerve rats based on KEGG pathway prediction and experimental verification", Evid Based Complement Alternat Med, 2020, pp.2545806~ (2020)
- Okada K, "Methylcobalamin increases Erk1", 2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model, 2010, pp.222, 191~203
- Nishimoto S, "Methylcobalamin promotes the differentiation of Schwann cells and remyelination in lysophosphatidylcholine-induced demyelination of the rat sciatic nerve", Front Cell Neurosci, 9, pp.298~ (2015)
- Liao WC, "Methylcobalamin facilitates collateral sprouting of donor axons and innervation of recipient muscle in end-toside neurorrhaphy in rats", PLoS One, 8, pp.e76302~ (2013)
- Sawangjit R, "Efficacy and safety of mecobalamin on peripheral neuropathy : a systematic review and meta-analysis of randomized controlled trials", J Altern Complement Med, 26, pp.1117~1129 (2020)
- Sil A, "A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500 mcg vs. a single dose methylcobalamin of 1500 mcg in patients with peripheral neuropathy", Korean J Pain, 31, pp.183~190 (2018)
